Blood, toxins, cultures, medical use, nes300290 (Harmonized System 1992 for 6-digit)
2021 World Trade: $12.4B, Rnk 285 / 4641
2021 Top Exporter | Top Importer: $3.38B | $1.66B, United States | United States
2021 Product Complexity: 0.75, Rnk 1180 / 4648
2020 - 2021 Export Growth (CAGR): 19.5%, Rnk 2425 / 4641
2018 Mean Tariff: 1.48%, Rnk 6357 / 6538
2021 Share of World Trade: 0.00059%, Rnk 285 / 4641
Overview This page contains the latest trade data of Blood, toxins, cultures, medical use, nes. In 2021, Blood, toxins, cultures, medical use, nes were the world's 285th most traded product, with a total trade of $12.4B. Between 2020 and 2021 the exports of Blood, toxins, cultures, medical use, nes grew by 19.5%, from $10.3B to $12.4B. Trade in Blood, toxins, cultures, medical use, nes represent 0.00059% of total world trade.
Blood, toxins, cultures, medical use, nes are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2021 the top exporters of Blood, toxins, cultures, medical use, nes were United States ($3.38B), Ireland ($2.77B), Germany ($1.16B), United Kingdom ($882M), and France ($647M).
Imports In 2021 the top importers of Blood, toxins, cultures, medical use, nes were United States ($1.66B), Germany ($1.13B), China ($1.08B), Ireland ($969M), and France ($767M).
Tariffs In 2018 the average tariff for Blood, toxins, cultures, medical use, nes was 1.48%, making it the 6357th lowest tariff using the HS6 product classification.
Ranking Blood, toxins, cultures, medical use, nes ranks 1180th in the Product Complexity Index (PCI).
Description Blood is typically used for transfusions. Toxins are used to extract poisons from patients and cultures are used to grow bacteria and fungi. Medical use is typically for diagnostic purposes.
The following visualization shows the latest trends on Blood, toxins, cultures, medical use, nes. Countries are shown based on data availability.
For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.
* Using January 2020 exchange rates when trade data is reported in local currency.
Trade By Country
Top Origin (2021): United States, $3.38B
Top Destination (2021): United States, $1.66B
Blood, toxins, cultures, medical use, nes are the world's 285th most traded product.
In 2021, the top exporters of Blood, toxins, cultures, medical use, nes were United States ($3.38B), Ireland ($2.77B), Germany ($1.16B), United Kingdom ($882M), and France ($647M).
In 2021, the top importers of Blood, toxins, cultures, medical use, nes were United States ($1.66B), Germany ($1.13B), China ($1.08B), Ireland ($969M), and France ($767M).
Trade by country
Top Origin Growth (2020 - 2021): United States, $1.02B
Top Destination Growth (2020 - 2021): China, $509M
Between 2020 and 2021, the exports of Blood, toxins, cultures, medical use, nes grew the fastest in United States ($1.02B), Germany ($315M), Switzerland ($152M), France ($138M), and Netherlands ($130M).
Between 2020 and 2021, the fastest growing importers of Blood, toxins, cultures, medical use, nes were China ($509M), Ireland ($477M), Germany ($284M), France ($217M), and United Kingdom ($206M).
Cumulative market share
This chart shows the evolution of the market concentration of exports of Blood, toxins, cultures, medical use, nes.
In 2021, market concentration measured using Shannon Entropy, was 3.57. This means that most of the exports of Blood, toxins, cultures, medical use, nes are explained by 11 countries.
This map shows which countries export or import more of Blood, toxins, cultures, medical use, nes. Each country is colored based on the difference in exports and imports of Blood, toxins, cultures, medical use, nes during 2021.
In 2021, the countries that had a largest trade value in exports than in imports of Blood, toxins, cultures, medical use, nes were Ireland ($1.8B), United States ($1.72B), Denmark ($455M), United Kingdom ($266M), and Switzerland ($221M).
In 2021, the countries that had a largest trade value in imports than in exports of Blood, toxins, cultures, medical use, nes were China ($962M), Canada ($395M), Brazil ($310M), Russia ($308M), and Japan ($220M).
This visualization shows the countries that have an important ratio of their trade related to Blood, toxins, cultures, medical use, nes. It is possible to select the main countries that export or import Blood, toxins, cultures, medical use, nes in the world, or by continent, as well as select the measure of interest.
The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v5.1.14 nutria